AbbVie
ABBV
#27
Rank
HK$3.042 T
Marketcap
HK$1,721
Share price
0.32%
Change (1 day)
28.54%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2025 (TTM): HK$13.06 Billion

According to AbbVie's latest financial reports the company's current earnings are HK$59.64 Billion. In 2024 the company made an earning of HK$28.97 Billion a decrease over its 2023 earnings that were of HK$48.73 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$13.06 B-54.92%
2024 HK$28.97 B-40.54%
2023 HK$48.73 B-53.62%
2022 HK$105.08 B3.76%
2021 HK$101.27 B282.25%
2020 HK$26.49 B-59.67%
2019 HK$65.69 B62.13%
2018 HK$40.52 B-32.74%
2017 HK$60.24 B-1.99%
2016 HK$61.47 B18.65%
2015 HK$51.81 B180.5%
2014 HK$18.47 B-55.57%
2013 HK$41.57 B-6.86%
2012 HK$44.63 B56.05%
2011 HK$28.60 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$92.41 B 613.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$62.63 B 383.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$175.46 B 1,255.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$64.27 B 396.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$77.08 B 495.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$14.84 B 14.70%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$72.69 B 461.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
HK$102.06 B 688.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$4.54 B-64.87%๐Ÿ‡บ๐Ÿ‡ธ USA